Recent Research on Human Papillomavirus (HPV) Infection and Vaccination

Persistent infection with high-risk human papillomavirus is associated with virtually all cervical cancers and a significant proportion of anogenital and oropharyngeal cancers. In recent years, significant progress has been made in cervical cancer prevention, especially in terms of the availability...

Description complète

Enregistré dans:
Détails bibliographiques
Format: Online
Langue:anglais
Publié: MDPI - Multidisciplinary Digital Publishing Institute 2025
Sujets:
Accès en ligne:ONIX_20250812T110751_9783725838639_218
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1869530948098326528
collection Directory of Open Access Books
description Persistent infection with high-risk human papillomavirus is associated with virtually all cervical cancers and a significant proportion of anogenital and oropharyngeal cancers. In recent years, significant progress has been made in cervical cancer prevention, especially in terms of the availability of prophylactic vaccines. However, the HPV vaccine has not yet achieved full coverage, and rates have dropped during the COVID-19 pandemic. It is therefore necessary to strengthen HPV vaccine education, vaccination and early prevention, especially in situations such as in low-income countries, where there are still multiple issues related to its dissemination and acceptance. Meanwhile, exploring the various aspects underlying the mechanism of progression of HPV-associated malignancies, host immune system reactions toward HPV viruses as well as HPV vaccination is important for the development of specific therapeutics and vaccines against viral clinical manifestations. Research areas of the Special Issue include discussing the knowledge and attitudes surrounding prophylactic HPV vaccination; vaccination implementation; effective instruments or interventions to improve public awareness of HPV vaccination; improving equity in HPV vaccination; the impact of the COVID-19 pandemic on HPV vaccination; host factors related to HPV infection, persistent, cervical intraepithelial neoplasia, and cervical cancer; co-infection of HPV with other pathogens; progression of HPV-associated malignancies; HPV and host–virus interaction; novel HPV vaccine development.
format Online
id doab-20.500.12854ir-165463
institution Directory of Open Access Books
language eng
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-1654632025-08-12T09:33:40Z Recent Research on Human Papillomavirus (HPV) Infection and Vaccination Shi, Li Yao, Yufeng HPV vaccine healthcare provider knowledge recommend influencing factor HPV vaccination healthcare students’ knowledge medical university education teachers adolescents HPV vaccine recommendations attitudes human papillomavirus (HPV) vaccine hesitancy key informant interviews focus groups qualitative research racially/ethnically diverse communities rural human papilloma virus type 16 (HPV16) immunoinformatics CTL epitope prediction multi-epitope vaccine design tumor immunotherapy Africa Sub-Saharan Africa girls women cervical cancer vaccination human papillomavirus vaccine hesitancy clinic-based multi-level intervention implementation quality improvement prevention oncology Serbia Montenegro clinical sampling human papillomavirus (HPV) biorepository saliva screening high-risk oral HPV nine-valent HPV vaccine therapeutic vaccination mucosal immunity CD8+ T cell responses thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics::MKZV Gene therapy Persistent infection with high-risk human papillomavirus is associated with virtually all cervical cancers and a significant proportion of anogenital and oropharyngeal cancers. In recent years, significant progress has been made in cervical cancer prevention, especially in terms of the availability of prophylactic vaccines. However, the HPV vaccine has not yet achieved full coverage, and rates have dropped during the COVID-19 pandemic. It is therefore necessary to strengthen HPV vaccine education, vaccination and early prevention, especially in situations such as in low-income countries, where there are still multiple issues related to its dissemination and acceptance. Meanwhile, exploring the various aspects underlying the mechanism of progression of HPV-associated malignancies, host immune system reactions toward HPV viruses as well as HPV vaccination is important for the development of specific therapeutics and vaccines against viral clinical manifestations. Research areas of the Special Issue include discussing the knowledge and attitudes surrounding prophylactic HPV vaccination; vaccination implementation; effective instruments or interventions to improve public awareness of HPV vaccination; improving equity in HPV vaccination; the impact of the COVID-19 pandemic on HPV vaccination; host factors related to HPV infection, persistent, cervical intraepithelial neoplasia, and cervical cancer; co-infection of HPV with other pathogens; progression of HPV-associated malignancies; HPV and host–virus interaction; novel HPV vaccine development. 2025-08-12T09:33:37Z 2025-08-12T09:33:37Z 2025 book ONIX_20250812T110751_9783725838639_218 9783725838639 9783725838646 https://directory.doabooks.org/handle/20.500.12854/165463 eng image/jpeg Attribution 4.0 International https://mdpi.com/books https://mdpi.com/books/pdfview/book/10834 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-3864-6 10.3390/books978-3-7258-3864-6 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725838639 9783725838646 158 open access
spellingShingle HPV vaccine
healthcare provider
knowledge
recommend
influencing factor
HPV vaccination
healthcare
students’ knowledge
medical university education
teachers
adolescents
HPV
vaccine
recommendations
attitudes
human papillomavirus (HPV) vaccine hesitancy
key informant interviews
focus groups
qualitative research
racially/ethnically diverse communities
rural
human papilloma virus type 16 (HPV16)
immunoinformatics
CTL epitope prediction
multi-epitope vaccine design
tumor immunotherapy
Africa
Sub-Saharan Africa
girls
women
cervical cancer
vaccination
human papillomavirus
vaccine hesitancy
clinic-based multi-level intervention
implementation
quality improvement
prevention
oncology
Serbia
Montenegro
clinical sampling
human papillomavirus (HPV)
biorepository saliva screening
high-risk oral HPV
nine-valent HPV vaccine
therapeutic vaccination
mucosal immunity
CD8+ T cell responses
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics::MKZV Gene therapy
Recent Research on Human Papillomavirus (HPV) Infection and Vaccination
title Recent Research on Human Papillomavirus (HPV) Infection and Vaccination
title_full Recent Research on Human Papillomavirus (HPV) Infection and Vaccination
title_fullStr Recent Research on Human Papillomavirus (HPV) Infection and Vaccination
title_full_unstemmed Recent Research on Human Papillomavirus (HPV) Infection and Vaccination
title_short Recent Research on Human Papillomavirus (HPV) Infection and Vaccination
title_sort recent research on human papillomavirus hpv infection and vaccination
topic HPV vaccine
healthcare provider
knowledge
recommend
influencing factor
HPV vaccination
healthcare
students’ knowledge
medical university education
teachers
adolescents
HPV
vaccine
recommendations
attitudes
human papillomavirus (HPV) vaccine hesitancy
key informant interviews
focus groups
qualitative research
racially/ethnically diverse communities
rural
human papilloma virus type 16 (HPV16)
immunoinformatics
CTL epitope prediction
multi-epitope vaccine design
tumor immunotherapy
Africa
Sub-Saharan Africa
girls
women
cervical cancer
vaccination
human papillomavirus
vaccine hesitancy
clinic-based multi-level intervention
implementation
quality improvement
prevention
oncology
Serbia
Montenegro
clinical sampling
human papillomavirus (HPV)
biorepository saliva screening
high-risk oral HPV
nine-valent HPV vaccine
therapeutic vaccination
mucosal immunity
CD8+ T cell responses
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics::MKZV Gene therapy
topic_facet HPV vaccine
healthcare provider
knowledge
recommend
influencing factor
HPV vaccination
healthcare
students’ knowledge
medical university education
teachers
adolescents
HPV
vaccine
recommendations
attitudes
human papillomavirus (HPV) vaccine hesitancy
key informant interviews
focus groups
qualitative research
racially/ethnically diverse communities
rural
human papilloma virus type 16 (HPV16)
immunoinformatics
CTL epitope prediction
multi-epitope vaccine design
tumor immunotherapy
Africa
Sub-Saharan Africa
girls
women
cervical cancer
vaccination
human papillomavirus
vaccine hesitancy
clinic-based multi-level intervention
implementation
quality improvement
prevention
oncology
Serbia
Montenegro
clinical sampling
human papillomavirus (HPV)
biorepository saliva screening
high-risk oral HPV
nine-valent HPV vaccine
therapeutic vaccination
mucosal immunity
CD8+ T cell responses
thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine
thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKZ Therapy and therapeutics::MKZV Gene therapy
url ONIX_20250812T110751_9783725838639_218